Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Doxofylline (10mg/ml) Injection
Therapeutic Category
Pulmonary, Respiratory, Asthma
Dosage Form
Injection
Packaging Type
Vial
Packaging
5x10ml
Price
₹149/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dozyfyle Injection contains Doxofylline (100mg), a bronchodilator that helps relax and open the airways in the lungs. Doxofylline works by inhibiting phosphodiesterase enzymes, leading to smooth muscle relaxation in the bronchial passages, which eases breathing in patients with obstructive airway conditions.
It helps in the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders where airway constriction and difficulty in breathing are present. It improves airflow, reduces wheezing, and helps patients breathe more comfortably during acute attacks or chronic management.
Common side effects include nausea, vomiting, headache, mild palpitations, or dizziness. Rarely, severe allergic reactions or heart rhythm disturbances may occur.
Indicated for patients with obstructive airway diseases such as asthma and COPD, particularly when bronchodilation is required to relieve symptoms like shortness of breath, wheezing, and chest tightness.
Administer only under medical supervision. Inform your doctor of any history of heart problems, arrhythmias, or hypersensitivity. The injection should be given as prescribed, and patients should be monitored during administration.
Store below 25°C in a cool, dry place, protected from light. Keep out of reach of children. Use immediately after preparation as instructed by healthcare professionals.
Composition : Doxofylline (400mg)
Composition : Doxofylline (650mg) SR
Composition : Doxofylline (400mg) + Ambroxol (30mg)
Composition : Doxofylline (400mg) + Montelukast (10mg)
Composition : Acebrophylline (100mg) Capsule
Composition : Levosalbutamol 100mcg + Ipratropium 40mcg
Composition : Fluticasone Propionate 500mcg + Formoterol Fumarate 12mcg Life Cap
Composition : Budesonide (200mcg) + Formoterol (6mcg) Rota Capsule
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Doxofylline oral liquid is used in the respiratory segment, making it a useful prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in asthma, COPD (chronic obstructive pulmonary disease), bronchospasm, wheezing, and other respiratory conditions. It is widely used in pediatric and general respiratory practice under medical supervision.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Doxofylline 100mg/5–10ml with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady prescription demand in asthma and bronchial disorders, repeat seasonal sales, and strong acceptance in respiratory practice when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.